潍坊医学院学报
濰坊醫學院學報
유방의학원학보
JOURNAL OF WEIFANG MEDICAL COLLEGE
2014年
2期
138-140
,共3页
老年人%舒芬太尼%右美托咪啶%靶控输注%体动反应%半数有效浓度
老年人%舒芬太尼%右美託咪啶%靶控輸註%體動反應%半數有效濃度
노년인%서분태니%우미탁미정%파공수주%체동반응%반수유효농도
Elderly%Sufentanil%Dexmedetomidine%Body movement%EC50
目的:探讨右美托咪啶对舒芬太尼抑制老年患者腹部手术切皮时体动反应的半数有效效应室靶浓度( EC50)的影响。方法择期行腹部手术患者50例,性别不限,年龄60~65岁,体重50~70kg,ASA分级Ⅰ级或Ⅱ级,随机分为右美托咪啶组(D组)和对照组(C组)。 D组用右美托咪啶0.5μg/mg加入20ml生理盐水10min内静脉泵注,C组用等量生理盐水静脉泵注。舒芬太尼靶控浓度从0.20μg/L开始,相邻靶浓度之间的比率为1.2。先行输注舒芬太尼,待其效应室浓度达0.07~0.09μg/L后开始输注丙泊酚,血浆靶浓度为2.4mg/L。达平衡后给予司考林1.5mg/kg,90s后插管(气管导管及声门充分表麻)接麻醉呼吸机行机控呼吸,10min后切皮,记录切皮1min内有无体动反应。然后静脉注射0.6mg/kg罗库溴铵,继续进行手术。记录切皮时各组舒芬太尼用量和患者有无体动反应。结果 D组19例入选,C组18例入选。 D组和C组各有7例患者切皮时出现体动反应。 D组舒芬太尼抑制切皮时体动反应的EC50为0.1148μg/L,95%可信区间为0.1055~0.1249μg/L;C组舒芬太尼抑制切皮时体动反应的EC50为0.1454μg/L,95%可信区间为0.1339~0.1580μg/L,D组比C组减少21%(P<0.05)。结论手术前缓慢静脉注射0.5μg/kg右美托咪啶可显著减少舒芬太尼抑制老年患者腹部手术切皮时体动反应的半数有效浓度和舒芬太尼的用量。
目的:探討右美託咪啶對舒芬太尼抑製老年患者腹部手術切皮時體動反應的半數有效效應室靶濃度( EC50)的影響。方法擇期行腹部手術患者50例,性彆不限,年齡60~65歲,體重50~70kg,ASA分級Ⅰ級或Ⅱ級,隨機分為右美託咪啶組(D組)和對照組(C組)。 D組用右美託咪啶0.5μg/mg加入20ml生理鹽水10min內靜脈泵註,C組用等量生理鹽水靜脈泵註。舒芬太尼靶控濃度從0.20μg/L開始,相鄰靶濃度之間的比率為1.2。先行輸註舒芬太尼,待其效應室濃度達0.07~0.09μg/L後開始輸註丙泊酚,血漿靶濃度為2.4mg/L。達平衡後給予司攷林1.5mg/kg,90s後插管(氣管導管及聲門充分錶痳)接痳醉呼吸機行機控呼吸,10min後切皮,記錄切皮1min內有無體動反應。然後靜脈註射0.6mg/kg囉庫溴銨,繼續進行手術。記錄切皮時各組舒芬太尼用量和患者有無體動反應。結果 D組19例入選,C組18例入選。 D組和C組各有7例患者切皮時齣現體動反應。 D組舒芬太尼抑製切皮時體動反應的EC50為0.1148μg/L,95%可信區間為0.1055~0.1249μg/L;C組舒芬太尼抑製切皮時體動反應的EC50為0.1454μg/L,95%可信區間為0.1339~0.1580μg/L,D組比C組減少21%(P<0.05)。結論手術前緩慢靜脈註射0.5μg/kg右美託咪啶可顯著減少舒芬太尼抑製老年患者腹部手術切皮時體動反應的半數有效濃度和舒芬太尼的用量。
목적:탐토우미탁미정대서분태니억제노년환자복부수술절피시체동반응적반수유효효응실파농도( EC50)적영향。방법택기행복부수술환자50례,성별불한,년령60~65세,체중50~70kg,ASA분급Ⅰ급혹Ⅱ급,수궤분위우미탁미정조(D조)화대조조(C조)。 D조용우미탁미정0.5μg/mg가입20ml생리염수10min내정맥빙주,C조용등량생리염수정맥빙주。서분태니파공농도종0.20μg/L개시,상린파농도지간적비솔위1.2。선행수주서분태니,대기효응실농도체0.07~0.09μg/L후개시수주병박분,혈장파농도위2.4mg/L。체평형후급여사고림1.5mg/kg,90s후삽관(기관도관급성문충분표마)접마취호흡궤행궤공호흡,10min후절피,기록절피1min내유무체동반응。연후정맥주사0.6mg/kg라고추안,계속진행수술。기록절피시각조서분태니용량화환자유무체동반응。결과 D조19례입선,C조18례입선。 D조화C조각유7례환자절피시출현체동반응。 D조서분태니억제절피시체동반응적EC50위0.1148μg/L,95%가신구간위0.1055~0.1249μg/L;C조서분태니억제절피시체동반응적EC50위0.1454μg/L,95%가신구간위0.1339~0.1580μg/L,D조비C조감소21%(P<0.05)。결론수술전완만정맥주사0.5μg/kg우미탁미정가현저감소서분태니억제노년환자복부수술절피시체동반응적반수유효농도화서분태니적용량。
Objective Approach the effects of dexmedetomidine on half-effective target effect-site concentration of Sufentanil to inhibit body movement in elderly patients at the beginning of abdominal operation .Methods ASAⅠorⅡpatients (50 cases) of both sexes aged 60~65 years weighted 50~70kg undergoing abdominal operation were randomly divided into 2 groups:Dexmedetomidine(D) group re-ceived intravenous infusion of dexmedetomidine at 0.5μg/mg diluted into physiological saline 20ml respectively,the control group(C) was infused with physiological saline 20ml.Both groups(D and C) were finished in 10 minutes.The concentration of Sufentanil target-controlled was fixed at 0.20μg/L and the ratio of two close effect concentrations was 1.2.Infuse Sufentanil first and infuse Propofol when the effect-site concentration reached 0.07~0.09μg/L.The target plasma concentration was fixed at 2.4μg/mg.After the balance,infuse Scoline 1.5mg/kg.Intubate after 90 second ( Tracheal tube and glottis fully anesthetized ) and use controlled breathing with Anesthesia Ventilators .Opera-tions began after ten minutes and record the amount of body movement in the first minute .Then infuse Rocuronium 0.6mg/kg and continue the operation.Blood pressure,heart rate,SpO2,BIS value and the amount of body movement in every group were monitored .Results The EC50 of sufentanil in Dexmedetomidine group was 0.1148μg/L with 95%confidence level of 0.1055~0.1249μg/L,The EC50 of Sufentanil in control group was 0.1454μg/L with 95%confidence level of 0.1339~0.1580μg/L.Conclusion The dose of Sufentanil used in Dexme-detomidine group reduced about 21%than the control group .The dose of Sufentanil used in thyroidectomy obviously reduced with the Dexme-detomidine was given ,and the hemodynamicis was more stable during the operation .